Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK falters in Q2 as austerity measures bite

July 25, 2012
Sales and Marketing Benylsta, GSK, Q2, Seretide, Witty

GlaxoSmithKline posted a loss in its second quarter results, as pressure in mature markets continues to affect the firm. Pharmaceutical …

News

Europe looking to revamp clinical trial laws

July 25, 2012
Research and Development, Sales and Marketing EFPIA, EU, Europe, clinical trials

The European Commission has put forward new proposals aimed at revamping clinical trial laws. The legislation will replace rules that …

News
Forest labs image

FDA approves Forest’s COPD drug

July 25, 2012
Sales and Marketing COPD, FDA, Forest, Tudorza Pressair

US regulators have approved Forest Laboratories’ new chronic obstructive pulmonary disease (COPD) drug. Tudorza Pressair (aclidinium bromide) has been given …

News

Parexel’s BioPharm Unit to aid smaller R&D firms

July 25, 2012
Research and Development Parexel, R&D, biotech

Parexel has launched the Parexel BioPharm Unit – a new division focused on the needs of small and mid-sized biopharma …

News
bod_guiheen_lg

ADMA Biologics appoints Lawrence Guiheen to board of directors

July 25, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing ADMA Biologics, Lawrence Guiheen

Late-stage biotech firm ADMA Biologics has announced it has appointed Lawrence Guiheen to its board of directors. Guiheen said: “Having …

Appointment

Physios and podiatrists to gain new prescribing powers

July 25, 2012
Sales and Marketing Department of Health, GPs, Physios, government, prescribing

Physiotherapists and podiatrists are set to gain new prescribing powers by 2014.  Ministers are looking to amend medicines legislation so …

News
Xarelto image

NICE yes for Xarelto to treat blood clots

July 25, 2012
Sales and Marketing Bayer, DVT, NHS, NICE, Pradaxa, VTE, Xarelto

NICE is recommending Bayer’s Xarelto (rivaroxaban) for the treatment and prevention of deep vein thrombosis (DVT). The watchdog said in …

News
screen_shot_2012-07-24_at_15

Comms agency WCG expands team

July 24, 2012
Medical Communications London, WCG, healthcare comms

WCG has announced a string of appointments whilst also being ranked twelfth among healthcare firms in PRWeek’s UK league tables. …

Appointment
Velcade image

Speedy approval for Onyx’ multiple myeloma drug

July 24, 2012
Research and Development, Sales and Marketing FDA, Janssen, Kyprolis, Onyx, Takeda, Velcade

Onyx’ Kyprolis has gained an accelerated approval by the FDA to treat patients with late-stage multiple myeloma.  Kyprolis (carfilzomib), a …

News

Pfizer and Janssen’s Alzheimer’s drug fails

July 24, 2012
Research and Development, Sales and Marketing Alzheimer's, Janssen, Pfizer, bapineuzumab

Pfizer and Janssen’s investigational Alzheimer’s drug bapineuzumab is no better than placebo, according to a new study. The Phase III …

News
NICE image

NICE to assess high cost drugs for rare conditions

July 24, 2012
Sales and Marketing AGNSS, NHS, NICE, Rawlins, rare conditions

NICE is to be responsible next year for assessing high cost drugs for people with rare medical conditions as part …

News
Microneedles image

Microneedles could transform delivery of drugs to the eye

July 24, 2012
Manufacturing and Production, Research and Development AMD, avastin, microneedles

Researchers in the US have demonstrated for the first time that drugs can be successfully delivered to the eye using …

News

ABPI names new Medical, Innovation and Research director

July 24, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bina Rawal, Stephen Whitehead

The ABPI has named its new Medical, Innovation and Research director as Dr Bina Rawal, who will join the trade …

Appointment
uniQure's Glybera

EMA recommends first new gene therapy

July 24, 2012
Business Services, Research and Development, Sales and Marketing CHMP, EMA, Glybera, uniQure

Glybera is now on the cusp of becoming the first gene therapy treatment to be approved in the West. The …

News

Pharma buoys Albemarle results in second quarter

July 24, 2012
Manufacturing and Production Albemarle, manufacturing

Albemarle succumbed to pressure in the market in the second quarter as sales fell 8% to $685 million, although the …

News
Michael Ball

Supplier defect blamed in Hospira recall case

July 24, 2012
Manufacturing and Production FDA, Hospira, Michael Ball

Hospira has concluded that a supplier defect was the root cause of its recall of four cancer drugs in the …

News

Contract research news in brief

July 23, 2012
Research and Development Clinipace Worldwide, Medpace, Paraxel, Synexus, eResearch Technologies and invivodata

A round-up of recent developments in the contract research sector, including updates from Parexel, Medpace, Clinipace, Synexus and ERT.

News
120711-melanie-welham-300

BBSRC appoints new director of science

July 23, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing BBSRC, Melanie Welham

BBSRC the government-funded bioscience research organisation has announced the appointment of Professor Melanie Welham as director of science. Welham is …

Appointment
NHS image

CCGs already improving patient care

July 23, 2012
Sales and Marketing CCGs, Commissioning Board, GPs, NHS, NHSCC, reforms

Clinical Commissioning Groups – the new structures set up under the Health and Social Care Act to control most of …

News
johnosborn

Onyx appoints John Osborn as senior VP

July 20, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing John Osborn, Onyx

Onyx Pharmaceuticals has announced the appointment of John Osborn as senior vice president, Global Corporate Affairs. In his role, Osborn …

Appointment
The Gateway to Local Adoption Series

Latest content

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026